PROVIDER PROFILE · NPI 1952308801
Vincent FirrincieliM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
245
Unique beneficiaries
—
Total services
3,052
Distinct HCPCS
9
Medicare payment
$21K
Peer benchmark
Total Medicare services vs. 102 Allergy/ Immunology providers in NC — above median (cohort median 5,884).
PRESCRIBING · PART D · 2024
Total Rx claims
536
Beneficiaries
—
Total drug cost
$379K
Distinct drugs
17
Brand share
64.0%
Top prescribed drugs
Omalizumab63 claims
Montelukast Sodium60 claims
Fluticasone/Umeclidin/Vilanter54 claims
Albuterol Sulfate47 claims
Fluticasone Propionate37 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$228
Payment records
12
By payment type
Food and Beverage$194
Education$34
Top paying entities
Food and Beverage$194
Education$34
REFERRAL NETWORK
Where Vincent Firrincieli's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Karen Dunn Allergy/ Immunology · Raleigh, NC | 34 | 110 |
| SOLSTAS LAB PARTNERS GROUP LLC | 18 | 76 |
| REX HOSPITAL INC. | 13 | 46 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE